We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
Cap. Flow
+$1.17B
Cap. Flow %
9.66%
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$197M
2
BABA icon
Alibaba
BABA
+$190M
3
AMZN icon
Amazon
AMZN
+$161M
4
GDDY icon
GoDaddy
GDDY
+$135M
5
DIS icon
Walt Disney
DIS
+$132M

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Consumer Discretionary 23.99%
3 Technology 11.1%
4 Financials 8.14%
5 Industrials 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWG icon
926
NatWest
NWG
$72.8B
$1.02M 0.01%
+166,480
New +$1.09M
PCOM
927
DELISTED
Points.com Inc. Common Shares
PCOM
$1.01M 0.01%
+82,149
New +$1M
COLD icon
928
Americold
COLD
$4.17B
$1.01M 0.01%
31,266
-1,165,553
-97% -$36.9M
BXG
929
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
$1.01M 0.01%
+86,754
New +$1.11M
HGV icon
930
Hilton Grand Vacations
HGV
$3.98B
$1.01M 0.01%
+31,755
New +$945K
AXP icon
931
American Express
AXP
$229B
$1.01M 0.01%
8,155
+6,354
+353% +$746K
VMI icon
932
Valmont Industries
VMI
$9.61B
$1.01M 0.01%
+7,940
New +$990K
SGRY icon
933
Surgery Partners
SGRY
$1.98B
$1M 0.01%
+122,977
New +$1.23M
TCBI icon
934
Texas Capital Bancshares
TCBI
$4.28B
$1M 0.01%
+16,312
New +$991K
WM icon
935
Waste Management
WM
$95.5B
$998K 0.01%
8,652
+90
+1% +$9.77K
EWH icon
936
iShares MSCI Hong Kong ETF
EWH
$1.23B
$996K 0.01%
38,492
+9,892
+35% +$256K
MANU icon
937
Manchester United
MANU
$3.96B
$996K 0.01%
55,111
-20,582
-27% -$388K
SPNT icon
938
SiriusPoint
SPNT
$3.01B
$994K 0.01%
+96,363
New +$1.03M
PFS icon
939
Provident Financial Services
PFS
$3.11B
$988K 0.01%
+40,760
New +$1.03M
FOX icon
940
Fox Class B
FOX
$21.3B
$981K 0.01%
26,854
-73,032
-73% -$2.65M
CWK icon
941
Cushman & Wakefield Ltd
CWK
$3.07B
$978K 0.01%
54,671
-672,383
-92% -$12.3M
EVR icon
942
Evercore
EVR
$13.2B
$976K 0.01%
11,024
-23,294
-68% -$2.07M
SAGE
943
DELISTED
Sage Therapeutics
SAGE
$970K 0.01%
5,296
-17,549
-77% -$2.99M
GNL icon
944
Global Net Lease
GNL
$1.87B
$969K 0.01%
49,382
-49,732
-50% -$947K
BGSF icon
945
BGSF Inc
BGSF
$55.7M
$967K 0.01%
51,239
+41,158
+408% +$834K
MDY icon
946
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$967K 0.01%
+2,800
New +$979K
THR
947
DELISTED
Thermon Group Holdings
THR
$958K 0.01%
37,331
+3,996
+12% +$99.7K
HUBS icon
948
HubSpot
HUBS
$11.4B
$950K 0.01%
+5,571
New +$972K
PSX icon
949
Phillips 66
PSX
$83.3B
$946K 0.01%
10,114
-38,209
-79% -$3.43M
EGAN icon
950
eGain
EGAN
$187M
$941K 0.01%
115,669
-89,050
-43% -$805K

Similar funds

Marshall Wace's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.

  • Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
  • Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
  • Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
  • Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
  • Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.

Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.